博、硕士研究生导师简介




个人简介：
沈晓沛，男，1983年10月生，工学博士，教授，博士生导师，闽江****讲座教授。2006年毕业于中南大学计算机科学与技术专业，获工学学士学位，2013年毕业于电子科技大学生物医学工程专业，获工学博士学位。2013.12-2018.12于美国约翰霍普金斯大学医学院从事博士后研究工作。现任职于福建医科大学基础医学院生物信息学系，主要研究方向为复杂人类疾病的大数据分析，研究对象包括肿瘤、脓毒症和神经类疾病等。
部分发表论文：
1.Shen X*, Zhu G*, Liu R*, Viola D, Elisei R, Puxeddu E, et al. Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer. Journal of Clinical Oncology. 2018; 36(5):438-445 (IF=32.956)
2.Shen X, Liu R, Xing M. A six-genotype genetic prognostic model for papillary thyroid cancer. Endocrine-related Cancer. 2017; 24(1):41-52.
3.Wang F*, Yu X*, Shen X*, Zhu G, Huang Y, Liu R, Viola D, et al. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer. The Journal of Clinical Endocrinology and Metabolism. 2017; 102(9):3241-3250.
4.Zhang T*, Shen X*, Liu R, Zhu G, Bishop J, Xing M. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness. Oncotarget. 2017; 8(1):900-914.
5.Cheng W*, Shen X*, Xing M. Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer. PloS One. 2019; 14(10):e**
6.Wang F*, Zhao S*, Shen X, Zhu G, Liu R, Viola D, Elisei R, Puxeddu E, et al. BRAF V600E Confers Male Sex Disease-specific Mortality Risk in Patients with Papillary Thyroid Cancer. Journal of Clinical Oncology. 2018. Aug 2:JCO
7.Huang Y, Qu S, Zhu G, Wang F, Liu R, Shen X, Viola D, Elisei R, et al. BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment. Journal of the National Cancer Institute. 2018; Apr 1;110(4):362-370.


学术任职：
中国癌症防治杂志编委；
中国中医药信息学会人工智能分会理事；
中国抗癌协会肿瘤标志专业委员会肿瘤测序及大数据分析协作组委员；
Jama Oncology, Thyroid, International Journal of Cancer, Briefings in Bioinformatics, Bioinformatics, Frontiers in Genetics/Oncology等杂志长期审稿人。